BizSkills Academy has had the pleasure and honour to be part of the 12th Biovision Forum from the 4th – 6th April 2017 in Lyon – France. This event presents an excellent opportunity to meet and liaise with the best in the global health industry. We have compiled this article to sum up the proceedings at the forum and hopefully, help you to prepare or to convince an entrepreneurial friend who might be interested in health, Biotech and Medtech entrepreneurship industries to take all the necessary steps to be ready for the next year’s forum.
The event has a number of programs going on simultaneously, some spearheaded by partners, and other led by BIOVISION Forum organizers. Thus, the Biovision Forum is an event which is well organized and designed to suit the needs of Medtech, Biotech and E-health start-up companies who are looking to take their innovations to the next level. It is a great event for investors who are equally interested in funding or partnering with the best innovators in these industries. However, the Big Booster program of the event may break this rule, it is open to all start-up companies with great and promising innovations!
First, Mr. Florian Miguet from Clim8
We will start by introducing you to Mr. Florian Miguet one of the big booster participants in 2017. Mr. Florian Miguet is the CEO and the Co-founder of Clim8, a startup company which produces clothing adaptable to the body temperature requirements at any time and anywhere.
Using the Clim8 Apps both on Android and iOS; a client is able to take control of of the desired body temperature, as well as tracking your exercises and calories. So, with their invented clothing, each one of us will be able to customize his or her unique thermal profile or requirements.
This Mr. Florian Miguet assessment of the BigBooster Program and of his own company after participating in the Boston, USA BigBooster Camp.
For more information about the Clim8 company and the mazing work they are doing, please don’t hesitate to visit their website on: http://www.myclim8.com
As you read this article, you will be able to get a glimpse at each start-up company which has won awards in this year’s forum and the kind of innovations, services, and products they have developed or they presented at the forum. You will also have an opportunity to visit each company’s website to have a deeper understanding of what they are doing at the company level, this way, you will be able to know how to prepare your own company’s products, services, innovations for the next Biovision Forum which would take place in 2018, i.e. if you have entrepreneurial ambitions.
Whether a startup company, an academic institution, a non-profit organization with a key focus on global health and an established business, it is paramount you attend the next event. The Biovision forum discusses emerging issues in global health, which are pertinent to the future of all of us. For instance, Artificial Intelligence, the future of vaccines, Oncology; the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer and many other subjects were judiciously debated by experts and stakeholders at the forum. Of course, you would want to be part and parcel of such discussions in the forum and keep the conversations going past the forum, won’t you?
Secondly, Which Start-ups or Companies Fit into Which Categories in the Forum?
In the Biovision Forum, there is a stage for the main event i.e. the Prospective program. In the Prospective, topics like the future of vaccines, BREXIT, and so many other interesting global health’s crosscutting issues are discussed. Then, there are also breakout sessions for the Catalyser, Investor, and Big Booster programs; which go on simultaneously with the main event. So, you have a variety of interesting conversations to pick from.
There are also exhibitions spaces for start-ups and partners participating at the forum. If a specific start-up company wants to have private conversations for a prevailing deal-making opportunity, there is space provided for such discussions as well. So, the Biovision forum is a venue to make deals, to expand your network in the industry and above all else to learn from the best in the industry, who convene in Lyon City on annual basis.
The Medtech, Biotech, and E-health start-up companies at different levels have a partner and a friend in the Biovision Forum. Therefore, you must save the date for the 2018 Biovision Forum to be held in Lyon again, from the 17th – 19th April if you are a keen entrepreneur, setting up a company with some impressive breakthrough innovation.
For example, start-up companies seeking first seed capital are a great fit for the catalyser category, essentially still seeking to prove their innovative business models or concepts. The amount of funding sought by such start-up companies in this forum ranged from 300,000 Euros to 1.5 Million Euros. On the other hand, start-ups who have a readily proven and innovative business models, and are exploring opportunities around commercialisation of their products or services, fit very well into the investor category. Here, such start-up companies get opportunities to meet successful companies who can either acquire their innovations or meet venture capital firms and angel investors who are ready to invest in their businesses. The amount of investment thought in this category ranged from 700,000 Euros to 6 million Euros.
Finally, start-up companies who have working business concepts, prototypes or at least viable products or services and have business set up in one marketplace, for example their home country are a great fit for the Big Booster category. Additionally, these companies may be looking for market expansion opportunities in the international market space; including growing into the European, African, American and recently, the Chinese market.
Big Booster is a high-level international non-profit acceleration program built for start-ups from all business sectors, opening doors to non-Biotech, non-Medtech and non-E-health businesses as well. The program has a special partnership with the City of Lyon in France and Boston in the U.S. So, whatever business sector you are involved with today as a start-up company, Biovision Forum has a category that will suit you perfectly, given your business’ scaling up objectives. Big Booster’s deadline for this year’s applications is set on the 26th Sept 2017, if you are interested, please visit their website. We have shared a link at the end of this article.
So, Which Start-up Companies Emerged Winners and What Do They Do?
In this post, we will cover companies in the Catalyser and the Investor categories, we have already listened to a BigBooster Program participant in the video above, though there were many companies, we will not cover BigBooster in this section. As expressed by the Director of Biovision Mr. Christophe Dercamp; “Biovision has positioned itself around certain key goals: transforming innovative ideas into solutions beneficial to the public, working towards a more connected and patient-centred health, searching for nuggets of knowledge that drive tomorrow’s conversations on the outpost of discoveries of the future.”
If you have a strong interest in the field of Biotech, Medtech and E-health; and you are wondering about which start-up companies emerged the winners, and the kind of products, services or innovations they presented, below you will find a description of each company and a link to their website.
The Catalyser Category Winners
Most innovative project award went to GLYCODELETE
VIB is a life sciences research institute, based in Flanders, Belgium. They perform basic research with a strong focus on translating scientific results into pharmaceutical, agricultural and industrial applications. Visit them on: http://www.vib.be
Most innovative start-up went to LACLARÉE
To address current limitations of multifocal lenses, Laclarée proposes a new concept of variable focus eyeglasses, providing clear vision at all distances automatically, and on a large field of view. Based on a proprietary technology, the team is developing eyeglasses perfectly adapted to presbyopes’ vision with no compromise on the aesthetic. Visit them on: http://www.laclaree-vision.com
Catalyser committee special award went to OP2LYSIS
OP2LYSIS has developed the first treatment of haemorrhagic stroke, which affects 1.5 M patients every year. Visit them on: http://www.theraprot.fr/op2lysis
Investor Category Winners
The most promising and innovative Medtech Start-up went to LUMITHERA
LumiThera is developing a non-invasive treatment to prevent vision loss in patients with degenerative eye disease. Visit them on: https://www.lumithera.com
The most promising and innovative Biotech Start-up went to STEP PHARMA
Step Pharma is a biotechnology company discovering and developing proprietary small molecule therapeutics for the treatment of auto-immune deceases. Step’s lead program is selective modulators against specific immune cell populations which are the main drivers of auto-immune diseases. Visit them on: http://www.step-ph.com/
The investor conference selection committee special award went to MENSIA TECHNOLOGIES
Mensia Technologies has a product called Koala, which is a home-based non-invasive medical device for the care of ADHD. Visit them on: http://www.mensiatech.com
When Is the Next Biovision Forum Supposed to Take Place?
Actions to Be Taken if You Are Interested to Be at Biovision Forum Next Year:
What should you really do to have your company, start-up, new product or innovation set a footprint in this resourceful network at the next Biovision Forum?
We believe the very fast thing you need to do now, is to set your calendar reminder every three months, so you remember to check on Biovision Forum or Big Booster’s social media accounts and website for latest development in terms of procedures and deadlines for applications and so on.
The second thing which is wise to do right now, is to browse through the Biovision Forum website to find out which category that will best suit your start-up company and how you can best prepare yourself to participate or to have your start-up presented at the forum next year.